Bristol-Myers Squibb GmbH & Co. KGaA

Name: Bristol-Myers Squibb GmbH & Co. KGaA
Address: Arnulfstr. 29, München, Bayern, 80636, DE
Telephone: 08007242410

Pharmaceutical Companies · München

Bristol-Myers Squibb GmbH & Co. KGaA is the German subsidiary of US-amerikanischen Pharmaunternehmens mit Schwerpunkt auf Onkologie, based in München.

Content in German

The detailed company information on this page is provided in the original German language. You can use your browser's built-in translation feature to view it in English.

Right-click on the page and select "Translate to English" or use the translation icon in your browser's address bar.

Bristol-Myers Squibb GmbH & Co. KGaA – Address & Contact

Phone

Website

Email

Address

Arnulfstr. 29
80636 München

Bristol-Myers Squibb GmbH & Co. KGaA Overview

Bristol-Myers Squibb GmbH & Co. KGaA is a pharmaceutical company based in München, Bayern. The company operates in the German pharmaceutical market and is regulated by the BfArM (Federal Institute for Drugs and Medical Devices).

Activities & Products

Pharmaceutical companies such as Bristol-Myers Squibb GmbH & Co. KGaA develop, produce or distribute medicines for the German and international market. All authorised products are subject to approval and are regulated by BfArM or the European Medicines Agency (EMA).

About Bristol-Myers Squibb GmbH & Co. KGaA

Zelltherapien: Zukunft der personalisierten cancer treatment - und beyond that?

Location & Contact

Bristol-Myers Squibb GmbH & Co. KGaA can be reached at the following address: Arnulfstr. 29, 80636 München – Phone: 08007242410. For current information and enquiries, please contact the company directly.

More information: Pharmaunternehmen in Bayern or all Pharmaunternehmen in Germany on Sanoliste.

Frequently asked questions about Bristol-Myers Squibb GmbH & Co. KGaA

What does Bristol-Myers Squibb do?

Brisol-Myers Squibb GmbH & Co. KGaA develops therapeutische Lösungen for people with schweren Erkrankungen wie Krebs, Herz-Kreislon-Beschare, HIV and Hepatitis-C-Infektionen. Mit Zelltherapie and Proteinhomöostase sucht sie neue Therapieansätze for eine still bessere Medikation.

Bristol-Myers Squibb GmbH & Co. KGaA on social media

X (Twitter)

Facebook